Spasticity Registry Evaluating Epidemiology, Treatment Patterns and Clinical Needs
Withdrawn
- Conditions
- Muscle Spasticity
- Interventions
- Other: No Intervention
- Registration Number
- NCT02145650
- Lead Sponsor
- Allergan
- Brief Summary
This study will examine the epidemiology (incidence and control of a disease), burden, clinical need, and treatment patterns of spasticity in patients with a diagnosis of Cerebral Palsy (CP), Multiple Sclerosis (MS), Stroke, Spinal Cord Injury (SCI), or Traumatic Brain Injury (TBI).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
-Diagnosis of Cerebral Palsy (CP), Multiple Sclerosis (MS), Stroke, Spinal Cord Injury (SCI), or Traumatic Brain Injury (TBI) for a minimum of 3 months
Exclusion Criteria
-Participation in a spasticity clinical trial in the past 5 years.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description All Participants No Intervention Patients with a diagnosis of CP, MS, Stroke, SCI, or TBI will be evaluated for spasticity by their healthcare provider. Patients diagnosed with spasticity requiring treatment will be enrolled in the study. There is no intervention administered in this study.
- Primary Outcome Measures
Name Time Method Investigator Assessment of Spasticity Severity using a 5-Point Scale Day 1 Percentage of Participants with Spasticity not Receiving Treatment Day 1 Spasticity Symptom Assessment Score using a 21-item Questionnaire Day 1 Spasticity Impact Assessment Score using a 32-item Questionnaire Day 1
- Secondary Outcome Measures
Name Time Method Percentage of Participants with Spasticity Receiving Treatment Day 1 Referral Patterns for Spasticity Management Day 1 Spasticity Screening Tool Score using a 13-item Questionnaire Day 1